Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Therapeutic Targets
List of Issues
Volume 15, Issue 1

Expert Opinion on Therapeutic Targets

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Therapeutic Targets, Volume 15, Issue 1 (2011)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Therapeutic Targets, Volume 15, Issue 1 (2011)

See all volumes and issues

Vol 28, 2024 Vol 27, 2023 Vol 26, 2022 Vol 25, 2021 Vol 24, 2020 Vol 23, 2019 Vol 22, 2018 Vol 21, 2017 Vol 20, 2016 Vol 19, 2015 Vol 18, 2014 Vol 17, 2013 Vol 16, 2012 Volume 15, 2011 Vol 14, 2010 Vol 13, 2009 Vol 12, 2008 Vol 11, 2007 Vol 10, 2006 Vol 9, 2005 Vol 8, 2004 Vol 7, 2003 Vol 6, 2002 Vol 5, 2001 Vol 5, 2001 Vol 4, 2000 Vol 3, 1999 Vol 2, 1998 Vol 1, 1997

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Article

The promise and challenges of targeting RSK for the treatment of cancer

Anna L Stratford & Sandra E Dunn

Pages: 1-4

Published online: 11 Dec 2010

First Page PreviewforThe promise and challenges of targeting RSK for the treatment of cancer | Full Text | References | PDF (225.9 KB)

276 Views
10 CrossRef citations
0Altmetric

Perspective

Article

Paving the way for targeting RSK in cancer

Yves Romeo & Philippe P Roux

Pages: 5-9

Published online: 19 Oct 2010

AbstractforPaving the way for targeting RSK in cancer | Full Text | References | PDF (169.9 KB)

454 Views
48 CrossRef citations
0Altmetric

Reviews

Article

Targeting RSK2 in human malignancies

Sumin Kang & Jing Chen

Pages: 11-20

Published online: 25 Oct 2010

AbstractforTargeting RSK2 in human malignancies | Full Text | References | PDF (297.3 KB)

626 Views
24 CrossRef citations
0Altmetric

Article

Variation in hormone receptor and HER-2 status between primary and metastatic breast cancer: review of the literature

Cagatay Arslan MD, Ebru Sari MD, Sercan Aksoy MD & Kadri Altundag MD

Pages: 21-30

Published online: 24 Nov 2010

AbstractforVariation in hormone receptor and HER-2 status between primary and metastatic breast cancer: review of the literature | Full Text | References | PDF (208.4 KB)

632 Views
48 CrossRef citations
0Altmetric

Article

Emerging strategies for EphA2 receptor targeting for cancer therapeutics

Manish Tandon PhD, Sai Vikram Vemula MS & Suresh K Mittal PhD

Pages: 31-51

Published online: 11 Dec 2010

AbstractforEmerging strategies for EphA2 receptor targeting for cancer therapeutics | Full Text | References | PDF (630.2 KB)

1300 Views
184 CrossRef citations
0Altmetric

Article

PCM1–JAK2-fusion: a potential treatment target in myelodysplastic–myeloproliferative and other hemato-lymphoid neoplasms

Sylvia Hoeller MD, Christoph Walz MD, Andreas Reiter MD, Stephan Dirnhofer MD & Alexandar Tzankov MD

Pages: 53-62

Published online: 20 Nov 2010

AbstractforPCM1–JAK2-fusion: a potential treatment target in myelodysplastic–myeloproliferative and other hemato-lymphoid neoplasms | Full Text | References | PDF (528.8 KB)

423 Views
19 CrossRef citations
0Altmetric

Article

EGFR–PI3K–AKT–mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy

Christian Freudlsperger MD DDS, Jeffrey R Burnett BS, Jay A Friedman PhD, Vishnu R Kannabiran BS, Zhong Chen MD PhD & Carter Van Waes MD PhD

Pages: 63-74

Published online: 26 Nov 2010

AbstractforEGFR–PI3K–AKT–mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapy | Full Text | References | PDF (358.3 KB)

674 Views
118 CrossRef citations
0Altmetric

Article

The multivalent activity of the tissue factor–thrombin pathway in thrombotic and non-thrombotic disorders as a target for therapeutic intervention

Ioannis Mitroulis, Konstantinos Kambas, Panagiota Anyfanti, Michael Doumas & Konstantinos Ritis

Pages: 75-89

Published online: 10 Nov 2010

AbstractforThe multivalent activity of the tissue factor–thrombin pathway in thrombotic and non-thrombotic disorders as a target for therapeutic intervention | Full Text | References | PDF (421.8 KB)

198 Views
21 CrossRef citations
0Altmetric

Article

The CD4-like molecule LAG-3, biology and therapeutic applications

Sophie Sierro PhD, Pedro Romero MD & Daniel E Speiser MD

Pages: 91-101

Published online: 11 Dec 2010

AbstractforThe CD4-like molecule LAG-3, biology and therapeutic applications | Full Text | References | PDF (410.2 KB)

1961 Views
90 CrossRef citations
0Altmetric

Article

Targeting of adenosine receptors in ischemia–reperfusion injury

Victor E Laubach, Brent A French & Mark D Okusa

Pages: 103-118

Published online: 29 Nov 2010

AbstractforTargeting of adenosine receptors in ischemia–reperfusion injury | Full Text | References | PDF (347.9 KB)

285 Views
46 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

New targets and mechanisms of action for lipid-lowering and anti-inflammatory therapies in atherosclerosis: where does the field stand?

Stephen J Nicholls et al.

Review Article | Published online: 4 Jun 2024

Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies

Harry Ridgway et al.

Article | Published online: 3 Jun 2024

Cardiac conduction diseases: understanding the molecular mechanisms to uncover targets for future treatments

Tingting Li et al.

Review Article | Published online: 13 May 2024

The role of collagen triple helix repeat containing 1 (CTHRC1) in cancer development and progression

Chandra K. Singh et al.

Review Article | Published online: 11 May 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Therapeutic Targets (Vol.15, Iss.1, 2011)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?